PMID: 6109265Dec 1, 1980Paper

Is the mesocortical dopaminergic system involved in Parkinson disease?

Neurology
F Javoy-Agid, Y Agid

Abstract

Tyrosine hydroxylase was used to identify catecholaminergic neurons in the substantia nigra and ventral tegmental area of the human mesencephalon. High enzyme activity in the normal ventral tegmental area indicated the presence of numerous cathecholaminergic neurons, most likely dopamine cells. Tyrosine-hydroxylase activity was decreased in the ventral tegmental area of parkinsonian patients, implying a lesion of the mesocortical dopamine system in Parkinson disease.

Citations

Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·J M Graham, H J Sagar
Aug 6, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·J KulisevskyA Estévez-González
Feb 24, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·G Becker, D Berg
Feb 9, 2002·Annals of Neurology·Venkata S MattayDaniel R Weinberger
Feb 9, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Gurutz LinazasoroJavier Ruiz
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Suresh KumarMadhuri Behari
Sep 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·C L Comella, C G Goetz
Jan 1, 1985·Neuroradiology·I SteinerE Melamed
Dec 1, 1995·Italian Journal of Neurological Sciences·S GoriL Murri
Jan 1, 1990·Psychopharmacology·P DelagrangeA Rougeul
Jan 1, 1990·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·H Braak, E Braak
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·E H HeinonenM Scheinin
Jan 1, 1991·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·R VolpiV Coiro
Oct 18, 2011·Journal of Neural Transmission·L KrajcovicovaIrena Rektorova
Apr 1, 1987·Biological Psychiatry·W F HoffmanD E Casey
Feb 15, 1994·Biological Psychiatry·P Sachdev, A M Aniss
Oct 1, 1990·Brain Research·J de KeyserG Ebinger
Aug 1, 1982·Electroencephalography and Clinical Neurophysiology·M MyslobodskyH Radwan
Mar 23, 1984·European Journal of Pharmacology·M RubergY Agid
Apr 22, 1985·Life Sciences·D R Liskowsky, L T Potter
Oct 1, 1994·Pharmacology, Biochemistry, and Behavior·S J AlonsoM Rodriguez
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·J N Joyce
Nov 1, 1990·Behavioral and Neural Biology·E D LevinL L Butcher
Jan 1, 1987·Pharmacology & Therapeutics·A E Lang
Jan 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·G FinaliG L Piccinin
Feb 1, 1987·Biological Psychology·B F O'DonnellA J Phay
Jan 1, 1990·Clinical Neurology and Neurosurgery·C J Stam, M Bakker
Jul 31, 1985·Neuroscience Letters·D R Liskowsky, L T Potter
Oct 9, 1989·Neuroscience Letters·J De KeyserG Vauquelin
Sep 1, 1994·Brain Research. Cognitive Brain Research·P ViereggeD Kömpf
Sep 5, 2002·Neuropsychologia·Clay B HolroydMichael G H Coles
Nov 6, 2002·Neuropsychologia·V CzerneckiB Dubois
Jan 12, 1999·Mechanisms of Ageing and Development·P BariliF Amenta
Sep 23, 1997·Pharmacology, Biochemistry, and Behavior·S J AlonsoM Rodriguez
Jul 1, 1989·Behavioral and Neural Biology·S R McGurkL L Butcher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.